How big is the Biopharmaceutical CMO And CRO Market?

The Biopharmaceutical CMO And CRO Market size is expected to reach USD 78.17 billion in 2024 and grow at a CAGR of 6.70% to reach USD 115.35 billion by 2029. Read More

What is the current Biopharmaceutical CMO And CRO Market size?

In 2024, the Biopharmaceutical CMO And CRO Market size is expected to reach USD 78.17 billion. Read More

Who are the key players in Biopharmaceutical CMO And CRO Market?

Lonza Group AG, ICON Plc, Parexel International Corporation, Samsung Biologics and Charles River Laboratories International, Inc. are the major companies operating in the Biopharmaceutical CMO And CRO Market. Read More

Which is the fastest growing region in Biopharmaceutical CMO And CRO Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Biopharmaceutical CMO And CRO Market?

In 2024, the North America accounts for the largest market share in Biopharmaceutical CMO And CRO Market. Read More

What years does this Biopharmaceutical CMO And CRO Market cover, and what was the market size in 2023?

In 2023, the Biopharmaceutical CMO And CRO Market size was estimated at USD 72.93 billion. The report covers the Biopharmaceutical CMO And CRO Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Biopharmaceutical CMO And CRO Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Biopharmaceutical CMO And CROCompanies

This report lists the top Biopharmaceutical CMO And CRO companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Biopharmaceutical CMO And CRO industry.